Effect of hANP for prevention of atrial fibrillation after CABG: a randomised controlled trial.

Trial Profile

Effect of hANP for prevention of atrial fibrillation after CABG: a randomised controlled trial.

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Jun 2015

At a glance

  • Drugs Carperitide (Primary)
  • Indications Atrial fibrillation
  • Focus Therapeutic Use
  • Acronyms NU-HIT
  • Most Recent Events

    • 03 Jun 2015 Primary endpoint (Postoperative atrial fibrillation) has been met according to results published in Circulation: Arrhythmia and Electrophysiology.
    • 24 Jul 2011 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 20 Jul 2011 Actual Initiation Date changed from 1 Mar 1997 to 1 Nov 2001 as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top